3rd Gene Therapy for Neurological Disorders Europe
11. Jul 2022 to 13. Jul 2022 — Register Here
Don’t miss your chance to join Europe’s only industry-focused event specifically dedicated to overcoming the niche challenges of targeting the CNS with gene therapy. Access NEW content such as sharing MHRA insights on regulatory challenges, addressing Europe’s payer considerations with the NHS, discussing specific European clinical trial nuances and hearing from Europe’s leading neurosurgeons at the forefront of gene therapy delivery and devices.
EUCOPE will be leading the pre-conference Workshop D: Overcoming Gene Therapy Pricing & Reimbursement Challenges in Europe on 11 July at 1:30
As more gene therapy developers run clinical trials in Europe, the field must discuss the anticipated challenges ahead. Showcasing case studies of European approvals, and discussing current payer opinions, this workshop will enable you to improve your understanding of the European landscape as you advance your programs. EUCOPE’s Victor Maertens will lead this workshop.